Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
PT Infion is an Indonesian pharmaceutical company dedicated to the development, manufacturing, and marketing of high-quality generic and branded medicinal products. The company operates a modern manufacturing facility in Pasuruan, East Java, which is designed to meet Good Manufacturing Practice (GMP) standards. Infion's product portfolio spans several therapeutic areas, including cardiovascular health, metabolic diseases, anti-infectives, and central nervous system disorders. By focusing on affordability and accessibility, the company plays a significant role in supporting the Indonesian healthcare system and improving patient outcomes. Infion continues to expand its reach through strategic distribution networks across the Indonesian archipelago.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PT. Infion.